Unibest
← Back to patent-cliff list

Pesampator

Tier C — Watch / trade

Pesampator

Pfizer Inc.
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:AMPAR

Indications (approved):Cognitive impairment, Ankylosing spondylitis, Schizophrenia, 神经性听力损失

Regional status

US
Phase II
2016-08-29
EU
Phase II
2018-11-15
China
-
Japan
Phase II
2018-11-15

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 7 · Total yield 365 mg
PF-4958242-0081258963-55-1PF-4958242-0091258963-53-9PF-4958242-01010147-37-2PF-4958242-0111258963-57-3PF-4958242-012305832-67-1PF-4958242-001106-41-2PF-4958242-002285-69-8PF-4958242-0032166040-22-6PF-4958242-0041258963-45-9PF-4958242-005—PF-4958242-0061258963-51-7PF-4958242-0071258963-53-9API · Pesampator
CodeCAS No.Intermediate
PF-4958242-0081258963-55-1(3R,4R)-4-(4-bromophenoxy)tetrahydrofuran-3-amine
PF-4958242-0091258963-53-9(3S,4S)-4-(4-bromophenoxy)tetrahydrofuran-3-amine
PF-4958242-01010147-37-2propane-2-sulfonyl chloride
PF-4958242-0111258963-57-3N-((3S,4S)-4-(4-bromophenoxy)tetrahydrofuran-3-yl)propane-2-sulfonamide
PF-4958242-012305832-67-1(5-cyanothiophen-2-yl)boronic acid
PF-4958242-001106-41-24-bromophenol
PF-4958242-002285-69-83,6-dioxabicyclo[3.1.0]hexane
PF-4958242-0032166040-22-6(3R,4R)-4-(4-bromophenoxy)tetrahydrofuran-3-ol
PF-4958242-0041258963-45-9(3R,4R)-4-(4-bromophenoxy)tetrahydrofuran-3-yl methanesulfonate
PF-4958242-005-(3S,4S)-3-azido-4-(4-bromophenoxy)tetrahydrofuran
PF-4958242-0061258963-51-7(3R,4R)-3-azido-4-(4-bromophenoxy)tetrahydrofuran
PF-4958242-0071258963-53-9(3S,4S)-4-(4-bromophenoxy)tetrahydrofuran-3-amine

Frequently asked questions

What are the approved indications of Pesampator?

Approved indications include: Cognitive impairment, Ankylosing spondylitis, Schizophrenia, 神经性听力损失.

When does the Pesampator patent expire?

No public expiry year is available for Pesampator yet; this page updates once verified.

How many synthesis routes are recorded for Pesampator?

1 synthesis routes are recorded; the shortest is 7 steps with 365 mg total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Pesampator intermediates?

All intermediates in Pesampator routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Pesampator intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-10